Ultrasound Contrast Agent Safe During Stress Echocardiogram

	Tweet

Research conducted at the Methodist DeBakey Heart & Vascular Center in Houston shows that the use of ultrasound contrast agents during stress Echocardiograms is safe. These results, revealed at the 19th Annual Scientific Sessions of the American Society of Echocardiography, come just months after the U.S. Food and Drug Administration mandated a black box warning on labels of contrast agents used for cardiovascular ultrasound.

The risk of major adverse effects is no different in patients that received contrast during their stress Echocardiogram than in those who did not receive contrast, according to research findings. This held true even though contrast was more often used in patients with a higher cardiac risk profile.

“Contrast-enhanced stress echocardiography is a safe option to attain important diagnostic information for patients who need more testing than cardiac ultrasound alone,” said Dr. Kamran Shaikh, postdoctoral echocardiography fellow at the Methodist DeBakey Heart & Vascular Center. “Our research found no link between its use and adverse events or any reason why it shouldn’t be available to cardiologists whose patients would benefit from it.”

Contrast, a liquid that is clearly visible in imaging studies such as Echocardiograms, is injected into the heart to enhance the quality of the image.
The study examined 3,121 consecutive patients who underwent stress Echocardiograms from 2002 through 2007 at The Methodist Hospital.

Researchers evaluated demographics, contrast use, hemodynamics, ECG and wall motion changes, symptoms and arrhythmias. Contrast was administered in 1,879 of 3,121 patients (60 percent). None of the patients receiving an ultrasound contrast agent experienced sustained ventricular Tachycardia, ventricular fibrillation, cardiac arrest or death.

The research was conducted by Drs. Kamran Shaikh, Su Min Chang, Kathleen Rosendahl-Garcia, Miguel A. Quiñones, Sherif F. Nagueh, Karla M. Kurrelmeyer and William A. Zoghbi at Methodist DeBakey Heart & Vascular Center.

Source: Methodist Hospital, Houston

RELATED STORIES:
Scientists turn skin cells into beating heart muscle   Too many people get angioplasties, study suggests   New Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA   Heart Damage After Chemo Linked to Stress in Cardiac Cells   What’s good or bad for the heart, may be the same for the brain   Warfarin in Heart Failure   Increased Sudden Cardiac Death Rate Among HIV Patients   Air pollution level changes in Beijing linked with biomarkers of cardiovascular disease   Lack of basic evidence hampering prevention of sudden heart attacks in sport   Blacks Less Likely to Get Help on Scene After Cardiac Arrest: Study   Heart attack patients taken to PCI hospitals first treated faster   Cameron Health’s under-skin ICD safe, effective

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]